Clinical Trial Update: Effects of Dexmedetomidine in Patients With Agitated Delirium in Palliative Care [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial evaluating dexmedetomidine for agitation in delirium among palliative care patients; currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Delirium

Drugs mentioned

• Dexmedetomidine (Precedex) (dexmedetomidine)

Snippet

Sponsor: Bruyère Health Research Institute. | Conditions: Hyperactive Delirium, Delirium of Mixed Origin | Phase 1, Phase 2 | Status: RECRUITING